• 10834 Citations
  • 55 h-Index
19992020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2020

Benefits of implementing a rapid access clinic in a high-volume inflammatory bowel disease center: Access, resource utilization and outcomes

Nene, S., Gonczi, L., Kurti, Z., Morin, I., Chavez, K., Verdon, C., Reinglas, J., Kohen, R., Bessissow, T., Afif, W., Wild, G., Seidman, E., Bitton, A. & Lakatos, P. L., febr. 21 2020, In : World journal of gastroenterology. 26, 8, p. 759-769 11 p.

Research output: Article

Open Access

Epidemiological data and utilization patterns of anti-TNF alpha therapy in the Hungarian ulcerative colitis population between 2012-2016

Kunovszki, P., Judit Szántó, K., Gimesi-Országh, J., Takács, P., Borsi, A., Bálint, A., Farkas, K., Milassin, Á., Lakatos, P. L., Szamosi, T. & Molnár, T., ápr. 2 2020, In : Expert Opinion on Biological Therapy. 20, 4, p. 443-449 7 p.

Research output: Article

Faecal calprotectin predicts endoscopic and histological activity in clinically quiescent ulcerative colitis

Hart, L., Chavannes, M., Kherad, O., Maedler, C., Mourad, N., Marcus, V., Afif, W., Bitton, A., Lakatos, P. L., Brassard, P. & Bessissow, T., jan. 1 2020, In : Journal of Crohn's and Colitis. 14, 1, p. 46-52 7 p.

Research output: Article

1 Citation (Scopus)
2 Citations (Scopus)

Low Rate of Drug Discontinuation, Frequent Need for Dose Adjustment, and No Association with Development of New Arthralgia in Patients Treated with Vedolizumab: Results from a Tertiary Referral IBD Center

Reinglas, J., Gonczi, L., Verdon, C., Bessissow, T., Afif, W., Wild, G., Seidman, E., Bitton, A. & Lakatos, P. L., júl. 1 2020, In : Digestive Diseases and Sciences. 65, 7, p. 2046-2053 8 p.

Research output: Article

1 Citation (Scopus)

Plasma Levels of C-Type Lectin REG3α and Gut Damage in People With Human Immunodeficiency Virus

Montreal Primary HIV Infection Study, the Canadian Cohort of HIV+ Slow Progressors, and the Canadian HIV and Aging Cohort Groups , jan. 1 2020, In : The Journal of infectious diseases. 221, 1, p. 110-121 12 p.

Research output: Article

2 Citations (Scopus)

The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases

Kim, H. U., Alten, R., Avedano, L., Dignass, A., Gomollón, F., Greveson, K., Halfvarson, J., Irving, P. M., Jahnsen, J., Lakatos, P. L., Lee, J. H., Makri, S., Parker, B., Peyrin-Biroulet, L., Schreiber, S., Simoens, S., Westhovens, R., Danese, S. & Jeong, J. H., febr. 1 2020, In : Drugs. 80, 2, p. 99-113 15 p.

Research output: Article

Open Access
1 Citation (Scopus)
2019

Biosimilars for the management of inflammatory bowel diseases: Economic considerations

Gulacsi, L., Pentek, M., Rencz, F., Brodszky, V., Baji, P., Vegh, Z., Gecse, K. B., Danese, S., Peyrin-Biroulet, L. & Lakatos, P. L., jan. 1 2019, In : Current medicinal chemistry. 26, 2, p. 259-269 11 p.

Research output: Article

10 Citations (Scopus)

Biosimilars in IBD: Will it benefit to patients, physicians or the health care system?

Gonczi, L., Ilias, A., Kurti, Z. & Lakatos, P., jan. 1 2019, In : Current pharmaceutical design. 25, 1, p. 13-18 6 p.

Research output: Article

2 Citations (Scopus)
1 Citation (Scopus)

Harmonization of quality of care in an IBD center impacts disease outcomes: Importance of structure, process indicators and rapid access clinic

Reinglas, J., Restellini, S., Gonczi, L., Kurti, Z., Verdon, C., Nene, S., Kohen, R., Afif, W., Bessissow, T., Wild, G., Seidman, E., Bitton, A. & Lakatos, P. L., márc. 2019, In : Digestive and Liver Disease. 51, 3, p. 340-345 6 p.

Research output: Article

4 Citations (Scopus)

Herpes Zoster Incidence in Inflammatory Bowel Disease Patients: A Population-Based Study

Côté-Daigneault, J., Bessissow, T., Nicolae, M. V., Nie, R., Bitton, A., Lakatos, P. L. & Brassard, P., ápr. 11 2019, In : Inflammatory bowel diseases. 25, 5, p. 914-918 5 p.

Research output: Article

5 Citations (Scopus)

High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, while Rates of Dysplasia are Low before the Suggested Onset of Surveillance

Singh, K., Al Khoury, A., Kurti, Z., Gonczi, L., Reinglas, J., Verdon, C., Kohen, R., Bessissow, T., Afif, W., Wild, G., Seidman, E., Bitton, A. & Lakatos, P. L., szept. 27 2019, In : Journal of Crohn's and Colitis. 13, 10, p. 1343-1350 8 p.

Research output: Article

Open Access
1 Citation (Scopus)

High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative Colitis Does Not Improve Colectomy-Free Survival

Chao, C. Y., Al Khoury, A., Aruljothy, A., Restellini, S., Wyse, J., Afif, W., Bitton, A., Lakatos, P. & Bessissow, T., febr. 15 2019, In : Digestive Diseases and Sciences. 64, 2, p. 518-523 6 p.

Research output: Article

4 Citations (Scopus)

Maladaptive coping, low self-efficacy and disease activity are associated with poorer patient-reported outcomes in inflammatory bowel disease

Chao, C. Y., Lemieux, C., Restellini, S., Afif, W., Bitton, A., Lakatos, P. L., Wild, G. & Bessissow, T., máj. 1 2019, In : Saudi Journal of Gastroenterology. 25, 3, p. 159-166 8 p.

Research output: Article

Open Access
1 Citation (Scopus)

Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: An Epi-IBD study

Burisch, J., Kiudelis, G., Kupcinskas, L., Kievit, H. A. L., Andersen, K. W., Andersen, V., Salupere, R., Pedersen, N., Kjeldsen, J., D'Incà, R., Valpiani, D., Schwartz, D., Odes, S., Olsen, J., Nielsen, K. R., Vegh, Z., Lakatos, P. L., Toca, A., Turcan, S., Katsanos, K. H. & 26 others, Christodoulou, D. K., Fumery, M., Gower-Rousseau, C., Zammit, S. C., Ellul, P., Eriksson, C., Halfvarson, J., Magro, F. J., Duricova, D., Bortlik, M., Fernandez, A., Hernández, V., Myers, S., Sebastian, S., Oksanen, P., Collin, P., Goldis, A., Misra, R., Arebi, N., Kaimakliotis, I. P., Nikuina, I., Belousova, E., Brinar, M., Cukovic-Cavka, S., Langholz, E. & Munkholm, P., márc. 1 2019, In : Gut. 68, 3, p. 423-433 11 p.

Research output: Article

19 Citations (Scopus)

Natural Disease Course of Ulcerative Colitis during the First Five Years of Follow-up in a European Population-based Inception Cohort - An Epi-IBD Study

Burisch, J., Katsanos, K. H., Christodoulou, D. K., Barros, L., Magro, F., Pedersen, N., Kjeldsen, J., Vegh, Z., Lakatos, P. L., Eriksson, C., Halfvarson, J., Fumery, M., Gower-Rousseau, C., Brinar, M., Čuković-Čavka, S., Nikulina, I., Belousova, E., Myers, S., Sebastian, S., Kiudelis, G. & 27 others, Kupcinskas, L., Schwartz, D., Odes, S., Kaimakliotis, I. P., Valpiani, D., D'Incà, R., Salupere, R., Chetcuti Zammit, S., Ellul, P., Duricova, D., Bortlik, M., Goldis, A., Kievit, H. A. L., Toca, A., Turcan, S., Midjord, J., Nielsen, K. R., Andersen, K. W., Andersen, V., Misra, R., Arebi, N., Oksanen, P., Collin, P., De Castro, L., Hernandez, V., Langholz, E. & Munkholm, P., febr. 1 2019, In : Journal of Crohn's and Colitis. 13, 2, p. 198-208 11 p.

Research output: Article

12 Citations (Scopus)

Outcomes of Patients With Inflammatory Bowel Diseases Switched From Maintenance Therapy With a Biosimilar to Remicade

Ilias, A., Szanto, K., Gonczi, L., Kurti, Z., Golovics, P. A., Farkas, K., Schafer, E., Szepes, Z., Szalay, B., Vincze, A., Szamosi, T., Molnar, T. & Lakatos, P. L., nov. 2019, In : Clinical Gastroenterology and Hepatology. 17, 12, p. 2506-2513.e2

Research output: Article

6 Citations (Scopus)

Patient and general population values for luminal and perianal fistulising Crohn’s disease health states

Rencz, F., Stalmeier, P. F. M., Péntek, M., Brodszky, V., Ruzsa, G., Gönczi, L., Palatka, K., Herszényi, L., Schäfer, E., Banai, J., Rutka, M., Gulácsi, L. & Lakatos, P. L., jún. 1 2019, In : European Journal of Health Economics. 20, p. 91-100 10 p.

Research output: Article

Open Access

Perceived Quality of Care is Associated with Disease Activity, Quality of Life, Work Productivity, and Gender, but not Disease Phenotype: A Prospective Study in a High-volume IBD Centre

Gonczi, L., Kurti, Z., Verdon, C., Reinglas, J., Kohen, R., Morin, I., Chavez, K., Bessissow, T., Afif, W., Wild, G., Seidman, E., Bitton, A. & Lakatos, P. L., szept. 1 2019, In : Journal of Crohn's and Colitis. 13, 9, p. 1138-1147 10 p.

Research output: Article

Open Access
3 Citations (Scopus)

Risk Factors Associated with Clostridium difficile infection in inflammatory bowel disease: A systematic review and meta-analysis

Balram, B., Battat, R., Al-Khoury, A., D’Aoust, J., Afif, W., Bitton, A., Lakatos, P. & Bessissow, T., jan. 1 2019, In : Journal of Crohn's and Colitis. 13, 1, p. 27-38 12 p.

Research output: Article

9 Citations (Scopus)

Risk of Malignant Cancers in Inflammatory Bowel Disease

Loo, S. Y., Vutcovici, M., Bitton, A., Lakatos, P. L., Azoulay, L., Suissa, S. & Brassard, P., szept. 27 2019, In : Journal of Crohn's and Colitis. 13, 10, p. 1302-1310 9 p.

Research output: Article

3 Citations (Scopus)

Screening for nonalcoholic fatty liver disease in inflammatory bowel diseases: A cohort study using transient elastography

Saroli Palumbo, C., Restellini, S., Chao, C. Y., Aruljothy, A., Lemieux, C., Wild, G., Afif, W., Lakatos, P., Bitton, A., Cocciolillo, S., Ghali, P., Bessissow, T. & Sebastiani, G., jan. 1 2019, In : Inflammatory bowel diseases. 25, 1, p. 124-133 10 p.

Research output: Article

13 Citations (Scopus)

Selection of Quality Indicators in IBD: Integrating Physician and Patient Perspectives

Bitton, A., Vutcovici, M., Lytvyak, E., Kachan, N., Bressler, B., Jones, J., Lakatos, P., Sewitch, M., El-Matary, W., Melmed, G. & Nguyen, G., jan. 10 2019, In : Inflammatory bowel diseases. 25, 2, p. 403-409 7 p.

Research output: Article

5 Citations (Scopus)

Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development

King, J. A., Underwood, F. E., Panaccione, N., Quan, J., Windsor, J. W., Kotze, P. G., Ng, S. C., Ghosh, S., Lakatos, P., Jess, T., Panaccione, R., Seow, C. H., Ben-Horin, S., Burisch, J., Colombel, J. F., Loftus, E. V., Gearry, R., Halfvarson, J. & Kaplan, G. G., ápr. 1 2019, In : The Lancet Gastroenterology and Hepatology. 4, 4, p. 287-295 9 p.

Research output: Article

6 Citations (Scopus)

Unmet Medical Needs in Ulcerative Colitis: An Expert Group Consensus

Danese, S., Allez, M., Van Bodegraven, A. A., Dotan, I., Gisbert, J. P., Hart, A., Lakatos, P. L., Magro, F., Peyrin-Biroulet, L., Schreiber, S., Tarabar, D., Vavricka, S., Halfvarson, J. & Vermeire, S., ápr. 1 2019, In : Digestive Diseases. 37, 4, p. 266-283 18 p.

Research output: Article

Open Access
3 Citations (Scopus)

Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s disease

Rencz, F., Lakatos, P. L., Gulácsi, L., Brodszky, V., Kürti, Z., Lovas, S., Banai, J., Herszényi, L., Cserni, T., Molnár, T., Péntek, M. & Palatka, K., jan. 15 2019, In : Quality of Life Research. 28, 1, p. 141-152 12 p.

Research output: Article

2 Citations (Scopus)
2018

Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition

Goncalves, J., Santos, M., Acurcio, R., Iria, I., Gouveia, L., Matos Brito, P., Catarina Cunha-Santos, A., Barbas, A., Galvão, J., Barbosa, I., Aires da Silva, F., Alcobia, A., Cavaco, M., Cardoso, M., Delgado Alves, J., Carey, J. J., Dörner, T., Eurico Fonseca, J., Palmela, C., Torres, J. & 12 others, Lima Vieira, C., Trabuco, D., Fiorino, G., Strik, A., Yavzori, M., Rosa, I., Correia, L., Magro, F., D'Haens, G., Ben-Horin, S., Lakatos, P. & Danese, S., szept. 1 2018, In : Alimentary Pharmacology and Therapeutics. 48, 5, p. 507-522 16 p.

Research output: Article

13 Citations (Scopus)

Comparative Effectiveness of Infliximab Versus Adalimumab in Patients with Biologic-Naïve Crohn’s Disease

Benmassaoud, A., Al-Taweel, T., Sasson, M. S., Moza, D., Strohl, M., Kopylov, U., Paradis-Surprenant, L., Almaimani, M., Bitton, A., Afif, W., Lakatos, P. & Bessissow, T., máj. 1 2018, In : Digestive Diseases and Sciences. 63, 5, p. 1302-1310 9 p.

Research output: Article

3 Citations (Scopus)

Cost-effectiveness of biological treatment sequences for fistulising Crohn’s disease across Europe

Baji, P., Gulácsi, L., Brodszky, V., Végh, Z., Danese, S., Irving, P. M., Peyrin-Biroulet, L., Schreiber, S., Rencz, F., Lakatos, P. L. & Péntek, M., márc. 1 2018, In : United European Gastroenterology Journal. 6, 2, p. 310-321 12 p.

Research output: Article

10 Citations (Scopus)

Development of an index to define overall disease severity in IBD

Siegel, C. A., Whitman, C. B., Spiegel, B. M. R., Feagan, B., Sands, B., Loftus, E. V., Panaccione, R., D'Haens, G., Bernstein, C. N., Gearry, R., Ng, S. C., Mantzaris, G. J., Sartor, B., Silverberg, M. S., Riddell, R., Koutroubakis, I. E., O'Morain, C., Lakatos, P. L., McGovern, D. P. B., Halfvarson, J. & 16 others, Reinisch, W., Rogler, G., Kruis, W., Tysk, C., Schreiber, S., Danese, S., Sandborn, W., Griffiths, A., Moum, B., Gasche, C., Pallone, F., Travis, S., Panes, J., Colombel, J. F., Hanauer, S. & Peyrin-Biroulet, L., febr. 1 2018, In : Gut. 67, 2, p. 244-254 11 p.

Research output: Article

40 Citations (Scopus)

ECCO-ESCP consensus on surgery for Crohn's disease

on behalf of the European Crohn's and Colitis Organisation , jan. 1 2018, In : Journal of Crohn's and Colitis. 12, 1, p. 1-16 16 p.

Research output: Article

Open Access
81 Citations (Scopus)

Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis–results from multicenter observational cohort

Bálint, A., Rutka, M., Kolar, M., Bortlik, M., Duricova, D., Hruba, V., Lukas, M., Mitrova, K., Malickova, K., Lukas, M., Szepes, Z., Nagy, F., Palatka, K., Lovas, S., Végh, Z., Kürti, Z., Csontos, Á., Miheller, P., Nyári, T., Bor, R. & 6 others, Milassin, Á., Fábián, A., Szántó, K., Lakatos, P. L., Molnár, T. & Farkas, K., nov. 2 2018, In : Expert Opinion on Biological Therapy. 18, 11, p. 1181-1187 7 p.

Research output: Article

4 Citations (Scopus)

Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis

Tornai, T., Tornai, D., Sipeki, N., Tornai, I., Alsulaimani, R., Fechner, K., Roggenbuck, D., Norman, G. L., Veres, G., Par, G., Par, A., Szalay, F., Lakatos, P. L., Antal-Szalmas, P. & Papp, M., dec. 1 2018, In : Scientific reports. 8, 1, 399.

Research output: Article

4 Citations (Scopus)

Optimizing patient management in crohn’s disease in a tertiary referral center: The impact of fast-track mri on patient management and outcomes

Ilias, A., Lovasz, B. D., Gonczi, L., Kurti, Z., Vegh, Z., Sumegi, L. D., Golovics, P. A., Rudas, G. & Lakatos, P., dec. 1 2018, In : Journal of Gastrointestinal and Liver Diseases. 27, 4, p. 391-397 7 p.

Research output: Article

Open Access
3 Citations (Scopus)

Quality of care indicators in inflammatory bowel disease in a tertiary referral center with open access and objective assessment policies

Gonczi, L., Kurti, Z., Golovics, P. A., Lovasz, B. D., Menyhart, O., Seres, A., Sumegi, L. D., Gal, A., Ilias, A., Janos, P., Gecse, K. B., Bessisow, T., Afif, W., Bitton, A., Vegh, Z. & Lakatos, P. L., jan. 2018, In : Digestive and Liver Disease. 50, 1, p. 37-41 5 p.

Research output: Article

5 Citations (Scopus)

Sex-Based Differences in Incidence of Inflammatory Bowel Diseases—Pooled Analysis of Population-Based Studies From Western Countries

Shah, S. C., Khalili, H., Gower-Rousseau, C., Olen, O., Benchimol, E. I., Lynge, E., Nielsen, K. R., Brassard, P., Vutcovici, M., Bitton, A., Bernstein, C. N., Leddin, D., Tamim, H., Stefansson, T., Loftus, E. V., Moum, B., Tang, W., Ng, S. C., Gearry, R., Sincic, B. & 8 others, Bell, S., Sands, B. E., Lakatos, P. L., Végh, Z., Ott, C., Kaplan, G. G., Burisch, J. & Colombel, J. F., okt. 2018, In : Gastroenterology. 155, 4, p. 1079-1089.e3

Research output: Article

29 Citations (Scopus)

Therapeutic drug monitoring guides the management of Crohn's patients with secondary loss of response to adalimumab

Restellini, S., Chao, C. Y., Lakatos, P., Aruljothy, A., Aziz, H., Kherad, O., Bitton, A., Wild, G., Afif, W. & Bessissow, T., jan. 1 2018, In : Inflammatory bowel diseases. 24, 7, p. 1531-1538 8 p.

Research output: Article

6 Citations (Scopus)

Therapeutic preferences and outcomes in newly diagnosed patients with Crohn's diseases in the biological era in Hungary: A nationwide study based on the National Health Insurance Fund database

Kurti, Z., Ilias, A., Gonczi, L., Vegh, Z., Fadgyas-Freyler, P., Korponay, G., Golovics, P. A., Lovasz, B. D. & Lakatos, P. L., jan. 30 2018, In : BMC gastroenterology. 18, 1, 23.

Research output: Article

Open Access
1 Citation (Scopus)
2017
Open Access
229 Citations (Scopus)

Access to biologicals in Crohn's disease in ten European countries

Crohn's Disease Research Group, szept. 14 2017, In : World Journal of Gastroenterology. 23, 34, p. 6294-6305 12 p.

Research output: Article

15 Citations (Scopus)

Cost-utility of biological treatment sequences for luminal Crohn’s disease in Europe

Rencz, F., Gulácsi, L., Péntek, M., Gecse, K. B., Dignass, A., Halfvarson, J., Gomollón, F., Baji, P., Peyrin-Biroulet, L., Lakatos, P. & Brodszky, V., nov. 2 2017, In : Expert Review of Pharmacoeconomics and Outcomes Research. 17, 6, p. 597-606 10 p.

Research output: Article

12 Citations (Scopus)

Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases

Gonczi, L., Kurti, Z., Rutka, M., Vegh, Z., Farkas, K., Lovasz, B. D., Golovics, P. A., Gecse, K. B., Szalay, B., Molnar, T. & Lakatos, P. L., aug. 8 2017, In : BMC gastroenterology. 17, 1, 97.

Research output: Article

10 Citations (Scopus)

ECCO Position statement on the use of biosimilars for inflammatory bowel disease-an update

Danese, S., Fiorino, G., Raine, T., Ferrante, M., Kemp, K., Kierkus, J., Lakatos, P. L., Mantzaris, G., van der Woude, J., Panes, J. & Peyrin-Biroulet, L., jan. 1 2017, In : Journal of Crohn's and Colitis. 11, 1, p. 26-34 9 p.

Research output: Article

Open Access
99 Citations (Scopus)

Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort

Bálint, A., Rutka, M., Végh, Z., Kürti, Z., Gecse, K. B., Banai, J., Bene, L., Gasztonyi, B., Kristóf, T., Lakatos, L., Miheller, P., Palatka, K., Patai, Á., Salamon, Á., Szamosi, T., Szepes, Z., Tóth, G. T., Vincze, A., Bor, R., Milassin, Á. & 13 others, Fábián, A., Nagy, F., Kolar, M., Bortlik, M., Duricova, D., Hruba, V., Lukas, M., Mitrova, K., Malickova, K., Lukas, M., Lakatos, P. L., Molnár, T. & Farkas, K., aug. 3 2017, In : Expert Opinion on Drug Safety. 16, 8, p. 885-890 6 p.

Research output: Article

11 Citations (Scopus)

Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis

Tornai, T., Palyu, E., Vitalis, Z., Tornai, I., Tornai, D., Antal-Szalmas, P., Norman, G. L., Shums, Z., Veres, G., Dezsofi, A., Par, G., Par, A., Orosz, P., Szalay, F., Lakatos, P. L. & Papp, M., aug. 7 2017, In : World journal of gastroenterology. 23, 29, p. 5412-5421 10 p.

Research output: Article

12 Citations (Scopus)

Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn’s disease and ulcerative colitis–experiences from a single center

Farkas, K., Rutka, M., Ferenci, T., Nagy, F., Bálint, A., Bor, R., Milassin, Á., Fábián, A., Szántó, K., Végh, Z., Kürti, Z., Lakatos, P. L., Szepes, Z. & Molnár, T., nov. 2 2017, In : Expert Opinion on Biological Therapy. 17, 11, p. 1325-1332 8 p.

Research output: Article

13 Citations (Scopus)

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab after One Year in a Prospective Nationwide Cohort

Gonczi, L., Gecse, K. B., Vegh, Z., Kurti, Z., Rutka, M., Farkas, K., Golovics, P. A., Lovasz, B. D., Banai, J., Bene, L., Gasztonyi, B., Kristof, T., Lakatos, L., Miheller, P., Nagy, F., Palatka, K., Papp, M., Patai, A., Salamon, A., Szamosi, T. & 6 others, Szepes, Z., Toth, G. T., Vincze, A., Szalay, B., Molnár, T. & Lakatos, P. L., nov. 1 2017, In : Inflammatory bowel diseases. 23, 11, p. 1908-1915 8 p.

Research output: Article

20 Citations (Scopus)